麻豆官网首页入口

Sejong Bae

Department Chair

Sejong Bae

Department Chair

Professor

Academic Appointment(s)

Administration
Department of Biostatistics, Data Science, & Epidemiology

Bio

Dr. Sejong Bae is a highly accomplished biostatistician and researcher with over two decades of experience in clinical, translational, and population-based research. Currently, he serves as the inaugural chair of the Department of Biostatistics, Data Science, and Epidemiology at 麻豆官网首页入口's School of Public Health, following significant academic and leadership roles, including a professorship at UAB Heersink School of Medicine and leadership of their Biostatistics & Bioinformatics Group for O鈥橬eal Comprehensive Cancer Center. Dr. Bae's extensive research interests encompass cancer, cardiovascular diseases, other chronic diseases, health equity, clinical trials, and advanced biostatistics methods, as reflected in his impressive publication record, which includes over 230 peer-reviewed manuscripts and more than 10,000 citations. He is highly involved in scientific review, having served on over 100 panels for organizations such as the NIH, DOD, VA, and PCORI. Additionally, he is a member or chair of several data and safety monitoring boards (DSMBs, DSMCs, and OSMBs).

  • (706) 729-2469
  • EB203

Education

  • Ph.D., Biostatistics University of Alabama at Birmi, 1999

  • MS, Statistics, Other University of Georgia, 1993

  • BS, Computer Science. University of Georgia, 1990

Scholarship

Selected Recent Publications

  • ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma, 2025
    Journal Article, Professional Journal
  • Cancer-related health behaviors during the COVID 19 pandemic in geographically diverse samples across the US, 2025
    Journal Article, Professional Journal
  • YIA25-001: Molecular Residual Disease (MRD) Guided Adjuvant Therapy In Renal Cell Carcinoma (RCC) - The MRD GATE RCC Study, 2025
    Journal Article, Professional Journal
  • Elevated CCL20 and IL-10 enhance 5-fluorouracil tolerance in colon cancer, 2025
    Journal Article, Academic Journal
  • Association of Race With Risk of Incident Cardiovascular Disease, Coronary Heart Disease, Heart Failure, and Stroke, 2025
    Journal Article, Academic Journal

Research Interests

cancer, cardiovascular diseases, other chronic diseases, health equity, clinical trials, and advanced biostatistics methods,

Professional Service

  • NIH 2025 - 2025

    Role: Reviewer, Grant Proposal